About: Sequenom

An Entity of Type: agent, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Sequenom (Nasdaq: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, and the SensiGene RHD Fetal RHD genotyping test.

thumbnail
Property Value
dbo:abstract
  • Sequenom (Nasdaq: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, and the SensiGene RHD Fetal RHD genotyping test. In June 2014 the company sold its biosciences unit to for up to $35.8 million. In July 2016, it was announced that diagnostic and testing giant LabCorp will acquire Sequenom, paying $2.40 for every outstanding share of Sequenom stock. The acquisition was completed in September 2016. (en)
dbo:industry
dbo:keyPerson
dbo:parentCompany
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 21659403 (xsd:integer)
dbo:wikiPageLength
  • 21201 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1107495461 (xsd:integer)
dbo:wikiPageWikiLink
dbp:homepage
dbp:industry
dbp:keyPeople
  • Dirk van den Boom (en)
dbp:locationCity
  • San Diego, CA (en)
dbp:locationCountry
  • USA (en)
dbp:logo
  • 220 (xsd:integer)
dbp:name
  • Sequenom (en)
dbp:parent
dbp:products
  • MaterniT21 PLUS, MaterniT GENOME, VisibiliT, HerediT CF, HerediT UNIVERSAL, NextView, SensiGene RHD (en)
dbp:services
  • Non-Invasive Prenatal Testing , Carrier Screening (en)
dbp:tradedAs
  • NYSE:SQNM (en)
dbp:type
  • Subsidiary (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Sequenom (Nasdaq: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, and the SensiGene RHD Fetal RHD genotyping test. (en)
rdfs:label
  • Sequenom (en)
owl:sameAs
skos:closeMatch
prov:wasDerivedFrom
foaf:depiction
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Sequenom (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License